| Wyeth and Ablynx Enter into Collaboration and Licence Agreement |
Abstract
pdf
|
|
Business Review Editor |
|
| Tanox Strikes Gold with Genentech Alliance |
Abstract
pdf
|
|
Business Review Editor |
|
| Abbott Takes its Speciality Pharma Pick |
Abstract
pdf
|
|
Business Review Editor |
|
| Are Purely Platform Technology Biotech Companies Playing a Shrinking Market? |
Abstract
pdf
|
|
Business Review Editor |
|
| Therapy Focus: Severe Sepsis and Septic Shock |
Abstract
pdf
|
|
Business Review Editor |
|
| Palomar Issues Another Sublicence for Hair-removal Technologies |
Abstract
pdf
|
|
Business Review Editor |
|
| AstraZeneca’s Disposal of the Humira® Royalty Stream to Royalty Pharma |
Abstract
|
|
Business Review Editor |
|
| Bradely Pharmaceuticals Increases Portfolio via BioSante |
Abstract
pdf
|
|
Business Review Editor |
|
| How 'Good' is Your Deal Sheet? |
Abstract
html
|
|
Fintan Walton |
|
| Sirna acquired by Merck for US$1.1 B |
Abstract
pdf
|
|
Business Review Editor |
|
| 3M Divests its Pharmaceutical Business |
Abstract
pdf
|
|
Business Review Editor |
|